Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years

• 主要な著者: Stanislav Filip (著者), Ondřej Kubeček (著者), Jiří Špaček (著者), Miriam Lánská (著者), Milan Bláha (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2020-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Cancer treatment has been greatly improved by the combined use of targeted therapies and novel biotechnological methods. Regarding the former, pegylated liposomal doxorubicin (PLD) has a preferential accumulation within cancer tumors, thus having lower toxicity on healthy cells. PLD has been impleme...